Big Pharma seeks to capitalize on cannabis compounds
The medicinal properties of cannabidiol (better known as CBD), a compound found in the Cannabis sativa L. plant species, are quickly drawing the attention of scientists, plant-medicine lovers, dietary-supplement companies, venture capitalists, professional athletes and Big Pharma - not to mention people living with serious, chronic medical conditions. Insiders predict the burgeoning market will be as profitable as the [...]